Global Drug of Abuse (DOA) Testing Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Drug of Abuse (DOA) Testing Revenue
• 1.4 Market by Type
  • 1.4.1 Global Drug of Abuse (DOA) Testing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Urine
  • 1.4.3 Saliva
  • 1.4.4 Hair
  • 1.4.5 Others
• 1.5 Market by Application
  • 1.5.1 Global Drug of Abuse (DOA) Testing Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospitals
  • 1.5.3 Laboratories
  • 1.5.4 Workplace
  • 1.5.5 At-Home
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Global Drug of Abuse (DOA) Testing Market Perspective (2015-2026)
• 2.2 Global Drug of Abuse (DOA) Testing Growth Trends by Regions
  • 2.2.1 Drug of Abuse (DOA) Testing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Drug of Abuse (DOA) Testing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Drug of Abuse (DOA) Testing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Drug of Abuse (DOA) Testing Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Drug of Abuse (DOA) Testing Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Drug of Abuse (DOA) Testing Players by Market Size
  • 3.1.1 Global Top Drug of Abuse (DOA) Testing Players by Revenue (2015-2020)
  • 3.1.2 Global Drug of Abuse (DOA) Testing Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Drug of Abuse (DOA) Testing Market Concentration Ratio
  • 3.2.1 Global Drug of Abuse (DOA) Testing Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Drug of Abuse (DOA) Testing Revenue in 2019
• 3.3 Drug of Abuse (DOA) Testing Key Players Head office and Area Served
• 3.4 Key Players Drug of Abuse (DOA) Testing Product Solution and Service
• 3.5 Date of Enter into Drug of Abuse (DOA) Testing Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

• 4.1 Global Drug of Abuse (DOA) Testing Historic Market Size by Type (2015-2020)
• 4.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

• 5.1 Global Drug of Abuse (DOA) Testing Market Size by Application (2015-2020)
• 5.2 Global Drug of Abuse (DOA) Testing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Drug of Abuse (DOA) Testing Market Size (2015-2020)
• 6.2 Drug of Abuse (DOA) Testing Key Players in North America (2019-2020)
• 6.3 North America Drug of Abuse (DOA) Testing Market Size by Type (2015-2020)
• 6.4 North America Drug of Abuse (DOA) Testing Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Drug of Abuse (DOA) Testing Market Size (2015-2020)
• 7.2 Drug of Abuse (DOA) Testing Key Players in Europe (2019-2020)
• 7.3 Europe Drug of Abuse (DOA) Testing Market Size by Type (2015-2020)
• 7.4 Europe Drug of Abuse (DOA) Testing Market Size by Application (2015-2020)

8 China

• 8.1 China Drug of Abuse (DOA) Testing Market Size (2015-2020)
• 8.2 Drug of Abuse (DOA) Testing Key Players in China (2019-2020)
• 8.3 China Drug of Abuse (DOA) Testing Market Size by Type (2015-2020)
• 8.4 China Drug of Abuse (DOA) Testing Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Drug of Abuse (DOA) Testing Market Size (2015-2020)
• 9.2 Drug of Abuse (DOA) Testing Key Players in Japan (2019-2020)
• 9.3 Japan Drug of Abuse (DOA) Testing Market Size by Type (2015-2020)
• 9.4 Japan Drug of Abuse (DOA) Testing Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Drug of Abuse (DOA) Testing Market Size (2015-2020)
• 10.2 Drug of Abuse (DOA) Testing Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Drug of Abuse (DOA) Testing Market Size by Type (2015-2020)
• 10.4 Southeast Asia Drug of Abuse (DOA) Testing Market Size by Application (2015-2020)

11 India

• 11.1 India Drug of Abuse (DOA) Testing Market Size (2015-2020)
• 11.2 Drug of Abuse (DOA) Testing Key Players in India (2019-2020)
• 11.3 India Drug of Abuse (DOA) Testing Market Size by Type (2015-2020)
• 11.4 India Drug of Abuse (DOA) Testing Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Drug of Abuse (DOA) Testing Market Size (2015-2020)
• 12.2 Drug of Abuse (DOA) Testing Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Drug of Abuse (DOA) Testing Market Size by Type (2015-2020)
• 12.4 Central & South America Drug of Abuse (DOA) Testing Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Siemens
  • 13.1.1 Siemens Company Details
  • 13.1.2 Siemens Business Overview
  • 13.1.3 Siemens Drug of Abuse (DOA) Testing Introduction
  • 13.1.4 Siemens Revenue in Drug of Abuse (DOA) Testing Business (2015-2020))
  • 13.1.5 Siemens Recent Development
• 13.2 Merck
  • 13.2.1 Merck Company Details
  • 13.2.2 Merck Business Overview
  • 13.2.3 Merck Drug of Abuse (DOA) Testing Introduction
  • 13.2.4 Merck Revenue in Drug of Abuse (DOA) Testing Business (2015-2020)
  • 13.2.5 Merck Recent Development
• 13.3 Roche
  • 13.3.1 Roche Company Details
  • 13.3.2 Roche Business Overview
  • 13.3.3 Roche Drug of Abuse (DOA) Testing Introduction
  • 13.3.4 Roche Revenue in Drug of Abuse (DOA) Testing Business (2015-2020)
  • 13.3.5 Roche Recent Development
• 13.4 Thermo Fisher Scientific
  • 13.4.1 Thermo Fisher Scientific Company Details
  • 13.4.2 Thermo Fisher Scientific Business Overview
  • 13.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Introduction
  • 13.4.4 Thermo Fisher Scientific Revenue in Drug of Abuse (DOA) Testing Business (2015-2020)
  • 13.4.5 Thermo Fisher Scientific Recent Development
• 13.5 Bio-Rad
  • 13.5.1 Bio-Rad Company Details
  • 13.5.2 Bio-Rad Business Overview
  • 13.5.3 Bio-Rad Drug of Abuse (DOA) Testing Introduction
  • 13.5.4 Bio-Rad Revenue in Drug of Abuse (DOA) Testing Business (2015-2020)
  • 13.5.5 Bio-Rad Recent Development
• 13.6 Abbott
  • 13.6.1 Abbott Company Details
  • 13.6.2 Abbott Business Overview
  • 13.6.3 Abbott Drug of Abuse (DOA) Testing Introduction
  • 13.6.4 Abbott Revenue in Drug of Abuse (DOA) Testing Business (2015-2020)
  • 13.6.5 Abbott Recent Development
• 13.7 Quest Diagnostics
  • 13.7.1 Quest Diagnostics Company Details
  • 13.7.2 Quest Diagnostics Business Overview
  • 13.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Introduction
  • 13.7.4 Quest Diagnostics Revenue in Drug of Abuse (DOA) Testing Business (2015-2020)
  • 13.7.5 Quest Diagnostics Recent Development
• 13.8 Express Diagnostics Int'l
  • 13.8.1 Express Diagnostics Int'l Company Details
  • 13.8.2 Express Diagnostics Int'l Business Overview
  • 13.8.3 Express Diagnostics Int'l Drug of Abuse (DOA) Testing Introduction
  • 13.8.4 Express Diagnostics Int'l Revenue in Drug of Abuse (DOA) Testing Business (2015-2020)
  • 13.8.5 Express Diagnostics Int'l Recent Development
• 13.9 Psychemedics
  • 13.9.1 Psychemedics Company Details
  • 13.9.2 Psychemedics Business Overview
  • 13.9.3 Psychemedics Drug of Abuse (DOA) Testing Introduction
  • 13.9.4 Psychemedics Revenue in Drug of Abuse (DOA) Testing Business (2015-2020)
  • 13.9.5 Psychemedics Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer